With Trump's appointment of Robert F. Kennedy Jr. as the secretary of Health and Human Services, the biotech industry has more questions than answers....

Last week, the federal government announced it will be cutting immigration in response to mounting economic pressures, including the cost and...

BMY has been having a good run for the past three months. The stock recently touched a 52-week high. We believe there is more room for growth, and any...

Despite recent setbacks and a 70% stock dip, SMCI's long-term growth potential and low valuation signal a buy.

NET's Q3 2024 results are likely to reflect benefits from an expanding clientele supported by its technological innovations despite macroeconomic...

MMM is making strides in the transportation and electrical markets, which makes the stock worth a watch amid certain headwinds.

MMM is making strides in the transportation and electrical markets, which makes the stock worth a watch amid certain headwinds.

AFRM's Q1 performance is likely to have been driven by higher card network revenues and growing GMV, partly offset by elevated expenses.

Sydney cafes are likely to introduce restrictions and limited stock availability of matcha, due to a global shortage of the green tea powder. Although...

Camtek's Q3 2024 results are likely to benefit from strong performance across its HPC segment, despite macroeconomic headwinds.